课题基金基金详情
血小板微粒促进血管钙化的作用及机制研究
结题报告
批准号:
81470561
项目类别:
面上项目
资助金额:
68.0 万元
负责人:
胡厚源
学科分类:
H0214.动脉粥样硬化与动脉硬化
结题年份:
2018
批准年份:
2014
项目状态:
已结题
项目参与者:
李佳蓓、贝俊杰、冯世斌、曲小龙、徐刚、陈强、肇炜博、张静
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
血管钙化(VC)是导致动脉粥样硬化(AS)斑块破裂的重要原因之一。研究表明,AS部位的炎症介质可诱导内皮细胞和血管平滑肌细胞(VSMCs)产生基质囊泡或凋亡小体,在促进AS斑块不稳定的同时,也参与了VC形成。我们前期研究发现,血小板激活后产生的微粒(PMPs)可促进单核细胞炎症介质的释放。同时,PMPs中含有与骨形成相关的miR-21、miR-223和骨钙素(OC)。因此我们推测,PMPs可能在促进VC中发挥重要作用。本项目拟研究PMPs与VSMCs的膜融合效应;探讨Ca2+、OC、miR-21和miR-223向VSMCs的转移,及其对VSMCs向成骨表型转化的调控作用和机制;并采用小鼠主动脉环体外培养模型,研究在高磷或无磷条件下,PMPs对VC的影响;体内实验研究PMPs促进apoE基因敲除小鼠VC形成的作用机制。旨在阐明PMPs促进VC的作用和机制,为血管钙化的防治提供新的策略和依据。
英文摘要
Vascular calcification is one of the main causes of atherosclerotic plaque rupture. Present studies have shown that inflammatory chemokines in the plaque induce endothelial cells and vascular smooth muscle cells (VSMCs) to release matrix vesicles or membrane niduses, and further to promote the calcification. We have found that platelet microparticles (PMPs) released by activated platelets can increase the secreation of inflammatory mediators by monocytes. PMPs also contain a lot of Ca2+, osteocalcin, miR-21 and miR-223, which are closely related to vascular calcification. The major assumption underlying this research is that PMPs may also play a crucial role in the accelerated formation of vascular calcification. The membrane fusion effect between PMPs and VSMCs will be studied using two-photon confocal microscopy and scanning electron microscopy. Using flow cytometry, qPCR and Western blot to evaluate the transfer of Ca2+, osteocalcin, miR-21 and miR-223 from PMPs into VSMCs. The osteogenic transition of VSMCs induced by PMPs, and the expression of the target genes in VSMCs regulated by miR-21 and miR-223, will be further studied. Mouse aortic ring organ calcification stimulated by PMPs in the condition of no or high-Pi will be studied.Animal experiments will be performed to study the promotion role and the mechanism of PMPs on vascular calcification in aorta of apoE gene knockout mice. All studies above should be very important for clarifying the mechanism of PMPs-promoted vascular calcification, and provide a novel strategy for the prevention of vascular calcification.
病理性异位钙化容易发生在心血管系统,是引起心血管事件的独立危险因素。动脉粥样硬化斑块中出现微钙化更容易发生破裂,而导致急性心脑血管事件的发生。钙化的血管组织中HMGB1表达明显增高,并且与巨噬细胞浸润、胶原蛋白分泌及微钙化发生密切相关。本研究发现:①高迁移率族蛋白通过RAGE/p38 MAPK/nSMase2信号通路促进巨噬细胞基质囊泡的释放。这方面的作用和机制已发表在PLoS ONE. 2016;11(5):e0156686. (IF: 3.057)。②系统评价和Meta分析的结果表明,PMPs在急性冠脉综合征的患者中显著升高,其水平与患者的预后相关,该结果发表在Canadian Journal of cardiology. 2016;32(11): 1325.e1-1325.e10. (IF 3.112)。③PMVs通过促进HUVECs表达和分泌MMP-2/9实现其促管腔形成和促迁移的作用。这方面的研究已发表在Cell Physiol Biochem. 2017;41:2319-2332. (IF= 5.104)。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFkappaB signalling pathway in monocytes
葡萄球菌 SSL5 诱导的血小板微粒通过单核细胞中的 CD40/TRAF6/NFkappaB 信号通路激发促炎反应
DOI:--
发表时间:2016
期刊:Thromb Haemost
影响因子:--
作者:Peter;K.;Hu;H. Y.
通讯作者:H. Y.
HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization.
HMGB1 诱导巨噬细胞分泌基质囊泡以增强异位矿化
DOI:10.1371/journal.pone.0156686
发表时间:2016
期刊:PloS one
影响因子:3.7
作者:Chen Q;Bei JJ;Liu C;Feng SB;Zhao WB;Zhou Z;Yu ZP;Du XJ;Hu HY
通讯作者:Hu HY
DOI:10.1160/th15-04-0322
发表时间:2016-03-01
期刊:THROMBOSIS AND HAEMOSTASIS
影响因子:6.7
作者:Bei, Jun-Jie;Liu, Chuan;Hu, Hou-Yuan
通讯作者:Hu, Hou-Yuan
Celastrol alleviates angiotensin II-mediated vascular smooth muscle cell senescence via induction of autophagy
雷公藤红素通过诱导自噬减轻血管紧张素 II 介导的血管平滑肌细胞衰老
DOI:10.3892/mmr.2017.7533
发表时间:2017
期刊:Molecular Medicine Reports
影响因子:3.4
作者:Xu Xian-Jie;Zhao Wei-Bo;Feng Shi-Bin;Sun Cheng;Chen Qiang;Ni Bing;Hu Hou-Yuan
通讯作者:Hu Hou-Yuan
DOI:10.1016/j.cjca.2016.02.052
发表时间:2016
期刊:Canadian Journal of Cardiology
影响因子:--
作者:Sun Cheng;Zhao Wei-Bo;Chen Yan;Hu Hou-Yuan
通讯作者:Hu Hou-Yuan
新型血小板膜仿生纳米递药系统的构建及其在逆转动脉粥样硬化易损斑块中的作用研究
血小板微粒促进动脉粥样硬化斑块内血管新生的作用及机制
血小板微粒在SSL5加速动脉硬化病变形成中的作用机制研究
以PSGL-1为靶向的融合蛋白TAP-SSL5抑制动脉粥样硬化和血栓形成的实验研究
以PSGL-1为靶向的融合蛋白SSL5-TAP的构建及其抑制动脉粥样硬化的实验研究
国内基金
海外基金